EDGAR·FLOW

Korsana Biosciences, Inc. — Form 8-K

Filed November 19, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 24/100
What the filing says
Korsana Biosciences filed Form 8-K on 2026-11-19 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) with period of report 2026-11-13. The filing contains no concrete details regarding what matter was submitted to stockholders, vote results, proposal specifics, share counts, or dollar amounts—only that such a vote occurred.
Why this rating

Vote filing is routine disclosure; no material transaction, financing, or outcome detail disclosed. Insufficient information to assess business impact relative to $5.7M market cap.

Extracted items
View original filing on SEC.gov ↗ KRSA · stock on Yahoo Finance ↗

See more from November 19, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.